Advertisement
Screener

Zoetis Inc. (ZTS) Cash Flow Breakdown

Zoetis Inc. Cash Flow Breakdown

Cash flow breakdown shows where Zoetis Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $2.90B came in.
  • Fiscal year ended 2025-12-31: from investing, $748.00M went out.
  • Fiscal year ended 2025-12-31: from financing, $1.87B went out.
  • Fiscal year ended 2025-12-31: change in cash, $325.00M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2025-12-31$2.90B-$748.00M-$3.23B-$889.00M-$1.35B$1.85B$0.00$9.00M-$3.00M$1.75B*$325.00M
2024-12-31$2.95B-$315.00M-$1.86B-$786.00M$0.00$0.00-$3.00M$20.00M$0.00-$33.00M*-$54.00M
2023-12-31$2.35B-$777.00M-$1.09B-$692.00M-$1.35B$0.00$1.00M$42.00M$0.00-$18.00M*-$1.54B
2022-12-31$1.91B-$883.00M-$1.59B-$611.00M$0.00$1.35B$2.00M$15.00M-$64.00M*$96.00M
2021-12-31$2.21B-$458.00M-$743.00M-$474.00M-$600.00M$0.00-$4.00M$36.00M-$77.00M*-$119.00M
2020-12-31$2.13B-$572.00M-$250.00M-$380.00M-$500.00M$1.24B$4.00M$57.00M-$48.00M*$1.67B
2019-12-31$1.79B-$504.00M-$626.00M-$314.00M$0.00$0.00-$9.00M$39.00M-$41.00M*$332.00M
2018-12-31$1.79B-$2.26B-$698.00M-$243.00M$0.00$1.50B$8.00M$36.00M-$66.00M*$38.00M
2017-12-31$1.35B-$270.00M-$500.00M-$206.00M-$750.00M$1.23B$0.00$35.00M-$61.00M*$837.00M
2016-12-31$713.00M-$214.00M-$300.00M-$188.00M-$400.00M$0.00-$5.00M$36.00M$0.00-$46.00M*-$427.00M
2015-12-31$664.00M-$1.11B-$203.00M-$168.00M$0.00$1.24B-$2.00M$9.00M$0.00-$117.00M*$272.00M
2014-12-31$626.00M-$187.00M$0.00-$146.00M$0.00$0.00-$8.00M-$2.00M*$272.00M
2013-12-31$681.00M-$179.00M$0.00-$98.00M$0.00$2.63B$16.00M-$184.00M-$2.56B*$293.00M
2012-12-31$454.00M-$135.00M-$63.00M$0.00$0.00$0.00-$15.00M$238.00M
2011-12-31$497.00M-$449.00M-$416.00M-$143.00M$0.00$0.00$529.00M$16.00M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperStaff share taxOtherNot split outChange in cash
2026-06-30$655.00M*-$300.00M*-$584.00M*-$223.00M*-$1.00M*-$5.00M*
2026-03-31$401.00M-$87.00M-$606.00M-$224.00M-$3.00M-$7.00M*-$509.00M
2025-12-31$893.00M*-$166.00M*-$2.06B*-$220.00M*$0.00*$0.00*$0.00*$1.78B*
2025-09-30$891.00M*-$167.00M*-$394.00M*-$222.00M*$0.00*-$2.00M*$484.00M*
2025-06-30$605.00M*-$212.00M*-$338.00M*-$223.00M*$0.00*$0.00*-$3.00M*
2025-03-31$515.00M-$203.00M-$443.00M-$224.00M$0.00-$1.00M-$9.00M*-$332.00M
2024-12-31$905.00M*$126.00M*-$553.00M*-$194.00M*$0.00*$0.00*$0.00*$2.00M*
2024-09-30$951.00M*-$178.00M*-$433.00M*-$197.00M*$0.00*$0.00*$0.00*$2.00M*
2024-06-30$502.00M*-$132.00M*-$533.00M*-$197.00M*$0.00*-$24.00M*$0.00*-$9.00M*
2024-03-31$595.00M-$131.00M-$339.00M-$198.00M$0.00$21.00M$0.00-$8.00M*-$66.00M
2023-12-31$897.00M*-$210.00M*-$235.00M*-$172.00M*$0.00*$1.00M*$9.00M*
2023-09-30$724.00M*-$271.00M*-$250.00M*-$173.00M*$0.00*$0.00*$7.00M*
2023-06-30$183.00M*-$80.00M*-$324.00M*-$173.00M*$0.00*-$1.00M*$4.00M*
2023-03-31$549.00M-$216.00M-$283.00M-$174.00M-$1.35B$1.00M$4.00M*-$1.47B
2022-12-31$741.00M*-$438.00M*-$405.00M*-$151.00M*$0.00*-$1.00M*$1.34B*
2022-09-30$526.00M*-$124.00M*-$377.00M*-$153.00M*$0.00*$1.00M*$0.00*
2022-06-30$336.00M*-$203.00M*-$451.00M*-$153.00M*$0.00*$2.00M*-$8.00M*
2022-03-31$309.00M-$118.00M-$361.00M-$154.00M$0.00$0.00-$30.00M*-$350.00M
2021-12-31$679.00M*-$142.00M*-$198.00M*-$117.00M*$0.00*$0.00*$1.00M*
2021-09-30$653.00M*-$114.00M*-$198.00M*-$119.00M*$0.00*-$4.00M*$2.00M*-$600.00M*
2021-06-30$481.00M*-$139.00M*-$166.00M*-$119.00M*-$5.00M*
2021-03-31$400.00M-$63.00M-$181.00M-$119.00M-$39.00M*-$2.00M
2020-12-31$718.00M*-$177.00M*$0.00*-$95.00M*-$500.00M*$3.00M*-$5.00M*
2020-09-30$562.00M*-$174.00M*$0.00*-$95.00M*$0.00*$0.00*$2.00M*
2020-06-30$438.00M*-$164.00M*$0.00*-$95.00M*$1.00M*$1.24B*
2020-03-31$408.00M-$57.00M-$250.00M-$95.00M$0.00$17.00M*$17.00M
2019-12-31$582.00M*-$213.00M*-$176.00M*-$79.00M*$0.00*$5.00M*$119.00M*
2019-09-30$506.00M*-$209.00M*-$150.00M*-$78.00M*$0.00*$0.00*-$4.00M*$60.00M*
2019-06-30$318.00M*-$59.00M*-$150.00M*-$78.00M*$0.00*$2.00M*$27.00M*
2019-03-31$389.00M-$23.00M-$150.00M-$79.00M-$9.00M-$5.00M*$126.00M
2018-12-31$584.00M*-$74.00M*-$150.00M*-$60.00M*$8.00M*$5.00M*$316.00M*
2018-09-30$550.00M*-$2.06B*-$143.00M*-$61.00M*$0.00*$1.47B*-$272.00M*
2018-06-30$267.00M*-$76.00M*-$215.00M*-$60.00M*$0.00*$4.00M*-$96.00M*
2018-03-31$389.00M-$45.00M-$190.00M-$62.00M$0.00-$10.00M*$90.00M
2017-12-31$608.00M*-$54.00M*-$125.00M*-$51.00M*-$750.00M*$0.00*-$41.00M*-$417.00M*
2017-10-01$439.00M*-$128.00M*-$125.00M*-$52.00M*$0.00*$0.00*$1.13B*$1.28B*
2017-07-02$180.00M*-$40.00M*-$125.00M*-$51.00M*$0.00*$0.00*$112.00M*$76.00M*
2017-04-02$119.00M-$48.00M-$125.00M-$52.00M$0.00$0.00$1.00M*-$98.00M
2016-12-31$286.00M*-$59.00M*-$75.00M*-$47.00M*$0.00*$0.00*-$6.00M*$76.00M*
2016-10-02$239.00M*-$124.00M*-$74.00M*-$47.00M*$0.00*-$4.00M*$1.00M*-$7.00M*
2016-07-03$137.00M*-$49.00M*-$75.00M*-$47.00M*$0.00*$0.00*$14.00M*-$17.00M*
2016-04-03$51.00M$18.00M-$76.00M-$47.00M-$400.00M-$1.00M-$19.00M*-$479.00M
2015-12-31$278.00M*-$737.00M*-$53.00M*-$41.00M*$0.00*-$4.00M*$1.12B*$562.00M*
2015-09-27$204.00M*-$60.00M*-$50.00M*-$42.00M*$0.00*$4.00M*$2.00M*$48.00M*
2015-06-28$122.00M*-$44.00M*-$52.00M*-$43.00M*$0.00*$3.00M*$1.00M*-$15.00M*
2015-03-29$60.00M-$274.00M-$48.00M-$42.00M$0.00-$5.00M$1.00M*-$323.00M
2014-12-31$387.00M*-$50.00M*$0.00*-$37.00M*$0.00*-$3.00M*-$2.00M*$284.00M*
2014-09-28$103.00M*-$42.00M*$0.00*-$36.00M*$0.00*-$3.00M*$0.00*$1.00M*$20.00M*
2014-06-29$159.00M*-$50.00M*$0.00*-$37.00M*$0.00*-$3.00M*$0.00*$1.00M*$72.00M*
2014-03-30-$23.00M-$45.00M$0.00-$36.00M$0.00$1.00M$0.00-$104.00M
2013-12-31$298.00M*-$51.00M*-$33.00M*$0.00*$5.00M*$0.00*$221.00M*
2013-09-29$114.00M*-$54.00M*-$32.00M*$1.00M*-$1.00M*$0.00*$20.00M*
2013-06-30-$12.00M*-$52.00M*-$33.00M*$0.00*$6.00M*$97.00M*-$102.00M*-$99.00M*
2013-03-31$281.00M-$22.00M$0.00$2.62B$6.00M-$281.00M-$2.46B*$151.00M
2012-12-31$310.00M*-$46.00M*$0.00*$0.00*$0.00*-$78.00M*$184.00M*
2012-09-30$74.00M*-$30.00M*-$1.00M*$0.00*$0.00*-$17.00M*$27.00M*
2012-07-01$74.00M*-$26.00M*-$10.00M*$0.00*$0.00*-$43.00M*-$7.00M*
2012-04-01-$4.00M-$33.00M-$52.00M$0.00$0.00$123.00M$34.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10